Biocorrx Inc (BICX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2024 | 12-2023 | 12-2022 | 12-2021 | 12-2020 | |
| Sales | 8 | 89 | 214 | 48 | 123 |
| Cost of Goods | 2 | 36 | 15 | 6 | 96 |
| Gross Profit | 6 | 53 | 199 | 42 | 27 |
| Operating Expenses | 5,130 | 3,877 | 4,912 | 5,558 | 7,615 |
| Operating Income | -5,123 | -3,788 | -4,698 | -5,510 | -7,492 |
| Interest Expense | 1,528 | 887 | 1,087 | 566 | 511 |
| Other Income | 1,438 | 904 | 1,408 | 865 | 4,497 |
| Pre-tax Income | -5,212 | -3,771 | -4,377 | -5,211 | -3,507 |
| Net Income Continuous | -5,212 | -3,771 | -4,377 | -5,211 | -3,507 |
| Minority Interests | -106 | -4 | 7 | 2 | -34 |
| Net Income | $-5,106 | $-3,767 | $-4,384 | $-5,213 | $-3,472 |
| EPS Basic Total Ops | -0.49 | -0.45 | -0.61 | -0.81 | -0.65 |
| EPS Basic Continuous Ops | -0.50 | -0.45 | -0.61 | -0.80 | -0.65 |
| EPS Diluted Total Ops | -0.49 | -0.45 | -0.61 | -0.81 | -0.65 |
| EPS Diluted Continuous Ops | -0.50 | -0.45 | -0.61 | -0.80 | -0.65 |
| EPS Diluted Before Non-Recurring Items | -0.49 | -0.44 | -0.61 | -0.79 | -0.65 |
| EBITDA(a) | $-3,925 | $-2,944 | $-4,061 | $-4,864 | $-6,845 |